Faveeuw C, Di Mauro M E, Price A A, Ager A
Division of Cellular Immunology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
Int Immunol. 2000 Mar;12(3):241-51. doi: 10.1093/intimm/12.3.241.
Several cell adhesion molecules that mediate the binding of lymphocytes to high endothelial venules (HEV) from flowing blood have been identified but the regulation of lymphocyte migration across the HEV wall into the lymph node (LN) is far from understood. In this study we have used an in vitro model of lymphocyte migration across HEV, and analysed the roles of two integrins in the binding and transendothelial migration of T lymphocytes and T lymphoblasts. The adhesion of T lymphocytes to high endothelial cells (HEC) cultured from rat LN HEV differed from that of T lymphoblasts since the percentage of T lymphoblasts that adhered and transmigrated was higher and was not increased by IFN-gamma pretreatment of HEC. Antibodies to alpha(4) integrins, VCAM-1 or LFA-1 maximally inhibited T lymphocyte adhesion by 40-50%, whereas antibodies to ICAM-1 were less effective (<20% inhibition). The effects of alpha(4) integrin and LFA-1 antibodies were additive, giving >90% inhibition. T lymphocytes which adhered in the presence of LFA-1 antibody showed reduced levels of transmigration and, in the presence of alpha(4) integrin antibody, slightly increased transmigration. Antibodies to alpha(4) integrins, VCAM-1, LFA-1 or ICAM-1 had little effect on T lymphoblast adhesion (maxima of 10-30% inhibition) and T lymphoblasts transmigrated normally in the presence of either alpha(4) integrin or LFA-1 antibodies. However, the effects of alpha(4) integrin and LFA-1 antibodies on T lymphoblast adhesion were synergistic, giving >90% inhibition of adhesion. These results suggest that the majority of T lymphoblasts use either alpha(4) integrins or LFA-1 to bind and transmigrate HEV, and the roles of these integrins on activated T cells are overlapping and redundant. In contrast, either integrin supports half-maximal binding of unactivated T lymphocytes to the surface of HEV and LFA-1 makes a larger contribution than alpha(4) integrins to transendothelial migration.
已鉴定出几种介导淋巴细胞与流动血液中的高内皮微静脉(HEV)结合的细胞粘附分子,但淋巴细胞穿过HEV壁迁移至淋巴结(LN)的调控机制仍远未明确。在本研究中,我们使用了淋巴细胞穿过HEV的体外模型,并分析了两种整合素在T淋巴细胞和T淋巴母细胞的结合及跨内皮迁移中的作用。T淋巴细胞与从大鼠LN的HEV培养的高内皮细胞(HEC)的粘附不同于T淋巴母细胞,因为粘附和迁移的T淋巴母细胞百分比更高,且HEC经IFN-γ预处理后该百分比并未增加。抗α(4)整合素、VCAM-1或LFA-1的抗体最大程度地抑制T淋巴细胞粘附达40 - 50%,而抗ICAM-1的抗体效果较差(抑制率<20%)。α(4)整合素和LFA-1抗体的作用是相加的,抑制率>90%。在LFA-1抗体存在下粘附的T淋巴细胞迁移水平降低,而在α(4)整合素抗体存在下,迁移略有增加。抗α(4)整合素、VCAM-1、LFA-1或ICAM-1的抗体对T淋巴母细胞粘附影响很小(最大抑制率为10 - 30%),并且T淋巴母细胞在α(4)整合素或LFA-1抗体存在下能正常迁移。然而,α(4)整合素和LFA-1抗体对T淋巴母细胞粘附具有协同作用,粘附抑制率>90%。这些结果表明,大多数T淋巴母细胞利用α(4)整合素或LFA-1来结合并穿过HEV,并且这些整合素在活化T细胞上的作用是重叠且冗余的。相比之下,任一整合素都支持未活化T淋巴细胞与HEV表面的半最大结合,并且LFA-1对跨内皮迁移的贡献比α(4)整合素更大。